The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

2016/05/07 by David N. Louis, Arie Perry, Guido Reifenberger +7 · 80 citations
Medicine · #Glioma Diagnosis and Treatment #Meningioma and schwannoma management #Brain Metastases and Treatment

paper · pdf · doi:10.1007/s00401-016-1545-1

Cited by

• cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”
• Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
• cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
• cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation
• cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant
• Multiclass magnetic resonance imaging brain tumor classification using artificial intelligence paradigm
• Brain and other central nervous system tumor statistics, 2021
• Management of glioblastoma: State of the art and future directions
• The current state of molecular testing in the treatment of patients with solid tumors, 2019
• Brain tumour histopathology through the lens of deep learning: A systematic review
• Estrogen and Progesterone Therapy and Meningiomas
• Tissue mechanics regulate brain development, homeostasis and disease
• Suppression of tumor growth via IGFBP3 depletion as a potential treatment in glioma
• Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
• A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma
• Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research
• Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
• Emerging Applications of Artificial Intelligence in Neuro-Oncology
• The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma
• Increased relative biological effectiveness and periventricular radiosensitivity in proton therapy of glioma patients
• A unified FLAIR hyperintensity segmentation model for various CNS tumor types and acquisition time points
• Atypical meningioma. A study on recurrence and disease-specific survival
• Glioma: molecular signature and crossroads with tumor microenvironment
• Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas
• Imaging features of rosette-forming glioneuronal tumours
• Usefulness of intraoperative rapid immunohistochemistry in the surgical treatment of brain tumors
• Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms
• Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4
• Compressed spectral screening for large-scale differential correlation analysis with application in selecting Glioblastoma gene modules
• APT‐weighted MRI: Techniques, current neuro applications, and challenging issues
• Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)
• Glioma grading and IDH1 mutational status: assessment by intravoxel incoherent motion MRI
• MRI-Based Brain Tumor Classification Using Ensemble of Deep Features and Machine Learning Classifiers
• Physics-Informed autoencoder for DSC-MRI Perfusion post-processing: application to glioma grading
• Cross-Platform DNA Methylation Classifier for the Eight Molecular Subtypes of Group 3 & 4 Medulloblastoma
• On the detectability by novices, radiologists, and computer algorithms of smallest increases in local single dot size in random-dot images
• How We Won BraTS-SSA 2025: Brain Tumor Segmentation in the Sub-Saharan African Population Using Segmentation-Aware Data Augmentation and Model Ensembling
• Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial
• Glioma infiltration and extracellular matrix: key players and modulators
• Vom Sinn für christlich-jüdische " Unschärferelationen" Zu Daniel Boyarins Border Lines.
• <scp>cIMPACT</scp>‐<scp>NOW</scp> update 10: Recommendations for defining new types for central nervous system tumor classification
• cIMPACT-NOW Update 12: Refining pathology-based risk stratification and grading for IDH-mutant gliomas
• Presurgical structural connectivity predicts postsurgical cognitive impairment in glioma patients
• EANS-EANO guidelines on the extent of resection in gliomas
• Network-Based Prediction of Oligodendroglioma Driver Gene Candidates within the Region of the 1p/19q Co-deletion Utilizing Single-Cell Transcriptomes
• Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation
• Predicting cognitive function 3 months after surgery in patients with a glioma
• A novel model of glioblastoma recurrence to identify therapeutic vulnerabilities
• Re-irradiation for children with diffuse intrinsic pontine glioma and diffuse midline glioma
• Therapy enhancing chromosome instability may be advantageous for <i>IDH1</i>R132H/WT gliomas
• A multifocal IDH-mutant glioma with differential response to IDH inhibition: Role of quantitative neuroimaging
• Evaluation and application of donors with primary central nervous system tumors
• Radiotherapy Effects on Diffuse Low-Grade Gliomas: Confronting Theory With Clinical Data
• Ganglioglioma revealed by spontaneous intracerebral hematoma: A cohort study
• Multiparametric Deep Learning and Radiomics for Tumor Grading and\n Treatment Response Assessment of Brain Cancer: Preliminary Results
• Diffuse leptomeningeal glioneuronal tumor [wikipedia]
• Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. [europepmc]
• Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study. [europepmc]
• Intertumoral Heterogeneity within Medulloblastoma Subgroups. [europepmc]
• The whole-genome landscape of medulloblastoma subtypes. [europepmc]
• Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. [europepmc]
• New Technologies for Analysis of Extracellular Vesicles. [europepmc]
• An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. [europepmc]
• Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M + diffuse midline gliomas. [europepmc]
• Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014. [europepmc]
• Multidimensional communication in the microenvirons of glioblastoma. [europepmc]
• cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV". [europepmc]
• Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid. [europepmc]
• Challenges to curing primary brain tumours. [europepmc]
• Genetic and molecular epidemiology of adult diffuse glioma. [europepmc]
• Longitudinal molecular trajectories of diffuse glioma in adults. [europepmc]
• Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networks. [europepmc]
• Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. [europepmc]
• Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. [europepmc]
• Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy. [europepmc]
• CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. [europepmc]
• Proteogenomic and metabolomic characterization of human glioblastoma. [europepmc]
• Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients. [europepmc]
• EANO guideline on the diagnosis and management of meningiomas. [europepmc]
• Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. [europepmc]
• Glioma progression is shaped by genetic evolution and microenvironment interactions. [europepmc]